Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Candesartan in Heart Failure (CHARM-Alternative)
NCT00634400Phase 3Completed
- Sponsor
- AstraZeneca
- Start
- Mar 1999
- Primary completion
- May 2003
- Modality
- Prodrugs/Conditional Activator Small Molecules
01
Overview
A Phase 3 trial of candesartan in heart failure (HF), sponsored by AstraZeneca. Started Mar 1999; status: completed.
02
Drugs
candesartan
03
Conditions
heart failure (HF)
Beyond the preview
Go deeper on NCT00634400.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00634400.